mirtazapine and chlorprothixene

mirtazapine has been researched along with chlorprothixene in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB1
Adomaitiene, V; Danileviciƫte, V; Fokas, V; Gumbrevicius, G; Sveikata, A; Sveikatiene, R1

Trials

1 trial(s) available for mirtazapine and chlorprothixene

ArticleYear
Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
    Medicina (Kaunas, Lithuania), 2009, Volume: 45, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Chlorprothixene; Controlled Clinical Trials as Topic; Data Collection; Data Interpretation, Statistical; Depression; Female; Humans; Lithuania; Male; Mental Health Services; Mianserin; Middle Aged; Mirtazapine; Observation; Olanzapine; Primary Health Care; Psychiatric Status Rating Scales; Remission Induction; Tablets; Time Factors; Treatment Outcome

2009

Other Studies

2 other study(ies) available for mirtazapine and chlorprothixene

ArticleYear
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2003, Volume: 103, Issue:11

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride

2003